These findings suggested that while RCC induced a substantial metabolic shift in surrounding non-malignant cells, SARS-CoV-2 S protein might not have as profound an effect on cellular metabolism as on immune responses. This evidence concerns the gene PROS1 and renal cell carcinoma.